S

Seegene Inc
KOSDAQ:096530

Watchlist Manager
Seegene Inc
KOSDAQ:096530
Watchlist
Price: 23 800 KRW 1.49% Market Closed
Market Cap: 1.2T KRW
Have any thoughts about
Seegene Inc?
Write Note

Seegene Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Seegene Inc
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
S
Seegene Inc
KOSDAQ:096530
Cash Equivalents
â‚©214.9B
CAGR 3-Years
-18%
CAGR 5-Years
37%
CAGR 10-Years
29%
Celltrion Inc
KRX:068270
Cash Equivalents
-â‚©440
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Bioscience Co Ltd
KRX:302440
Cash Equivalents
â‚©127B
CAGR 3-Years
72%
CAGR 5-Years
95%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Cash Equivalents
â‚©182.9B
CAGR 3-Years
61%
CAGR 5-Years
4%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Cash Equivalents
â‚©10.6B
CAGR 3-Years
-31%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Cash Equivalents
â‚©27B
CAGR 3-Years
15%
CAGR 5-Years
22%
CAGR 10-Years
N/A
No Stocks Found

Seegene Inc
Glance View

Market Cap
1.2T KRW
Industry
Biotechnology

Seegene, Inc. engages in the manufacturing and distributing of molecular diagnostics and reagents. The company is headquartered in Seoul, Seoul. The company went IPO on 2010-09-10. The firm mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The firm provides its products under the brand names of Seeplex, Anyplex and Magicplex. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
23 185.53 KRW
Overvaluation 3%
Intrinsic Value
Price
S

See Also

What is Seegene Inc's Cash Equivalents?
Cash Equivalents
214.9B KRW

Based on the financial report for Sep 30, 2024, Seegene Inc's Cash Equivalents amounts to 214.9B KRW.

What is Seegene Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
29%

Over the last year, the Cash Equivalents growth was 20%. The average annual Cash Equivalents growth rates for Seegene Inc have been -18% over the past three years , 37% over the past five years , and 29% over the past ten years .

Back to Top